Menu Back toFaculty

Regulatory Affairs for Combination Products

Attend this virtual training course to learn about FDA's approach to regulation of combination products, the processes to streamline development of single entity, and aligning requirements between drugs and devices.


  • Carol H. Danielson, DrPH, MS, RAC

    Carol H. Danielson, DrPH, MS, RAC

    • President
    • Regulatory Advantage, LLC, United States

    Ms Carol H. Danielson, Dr PH, RAC has provided regulatory expertise and leadership for more than twenty five years for drugs, biologics and medical devices from discovery through post-marketing. Her areas of specialization include regulatory strategy and submissions, clinical affairs and compliance, and quality assurance and control. Her background includes both extensive “hands on” experience and corporate level strategy activities from partnering due diligence to serving as an expert witness in the drug development process.

Contact us

Registration Questions?

Send Email

Agenda and Event Logistics

Send Email